Insider Transactions in Q1 2025 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
8,000
-2.31%
|
$696,000
$87.01 P/Share
|
|
Jan 21
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+6.38%
|
$40,000
$5.35 P/Share
|
|
Jan 15
2025
|
Teri Loxam Director |
SELL
Open market or private sale
|
Direct |
6,250
-7.46%
|
$525,000
$84.54 P/Share
|
|
Jan 15
2025
|
Teri Loxam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+31.77%
|
$137,500
$22.7 P/Share
|
|
Jan 06
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
5,000
-5.15%
|
$425,000
$85.7 P/Share
|
|
Jan 06
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.08%
|
$105,000
$21.41 P/Share
|
|
Jan 02
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-1.26%
|
$664,000
$83.67 P/Share
|
|
Jan 02
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.61%
|
$16,000
$2.42 P/Share
|